Inventor

SILENCE KAREN

BE23 patents

⚠️ This page may combine multiple inventors who share the name “SILENCE KAREN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SILENCE KAREN

ABLYNX NV

Single domain VHH antibodies against von Willebrand factor

Single domain VHH antibodies against Von Willebrand Factor

Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor

Pulmonary administration of immunoglobulin single variable domains and constructs thereof

Pulmonary administration of immunoglobulin single variable domains and constructs thereof

Polypeptides and polypeptide constructs comprising single domain antibodies directed against von willebrand factor

Polypeptides and polypeptide constructs comprising single domain antibodies directed against von Willebrand factor

SILENCE KAREN

Antibodies to CD70

Antibodies to CD70

Polypeptides and polypeptide constructs comprising single domain antibodies directed against von Willebrand factor

Polypeptide constructs including VHH directed against EGFR for intracellular delivery

argenx BV

Antibodies to CD70

FcRn/HSA binding molecules and methods of use

FCRN/antigen-binding molecules and methods of use

UNIV OF BERN

Anti-CD70 combination therapy

Anti-CD70 and BCR-ABL inhibitor combination therapy

ARGEN-X N V

Antibodies to CD70

MUYLDERMANS SERGE

Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof

UMC UTRECHT HOLDING BV

Methods and assays for distinguishing between different forms of diseases and disorders characterized by thrombocytopenia and/or by spontaneous interaction between Von Willebrand Factor (vWF) and platelets

ARGENX BVBA

Antibodies to CD70

ARGEN X N V

Chimeric human-llama antigens and methods of use

VLAAMS INTERUNIV INST BIOTECH

Recombinant phages capable of entering host cells via specific interaction with an artificial receptor

UNIV NEW YORK

Therapeutic musk antibodies